Thomson Medical Group - Phillip Securities 2024-09-16: A Year In Transition

Thomson Medical Group - A Year In Transition

Published:
Thomson Medical (SGX:A50) | SGinvestors.ioThomson Medical (SGX:A50)
  • Thomson Medical (SGX:A50)'s FY24 revenue met expectations. However, earnings swung to an adjusted net loss of S$10mil against our forecast profit of S$13mil. Operating margins disappointed due to several investment initiatives and lower project revenue. The acquisition of Vietnam healthcare operations was completed in December 2023.
  • - Read this at SGinvestors.io -
  • A new hospital in Johor is planned for completion in mid-2029 with the remaining 9.5ha land bank pending a development review.

The Positive

Rising revenue intensity or average bill size.

  • - Read this at SGinvestors.io -
  • Meanwhile, Singapore's revenue intensity jumped 18% to S$5,041 due to the rising complexity of gynaecology cases.

The Negative

Drop in volumes and margins.

  • Read more at SGinvestors.io.



Above is an excerpt from a report by Phillip Securities Research.
Clients of Phillip Capital may be the first to access the full PDF report @ https://www.stocksbnb.com/.



Paul Chew Phillip Securities Research | https://www.stocksbnb.com/ 2024-09-16



Read also Phillip's most recent report:
2025-02-18 Thomson Medical Group - Still Building The Foundations.

Price targets by other brokers at Thomson Medical Target Prices.

Listing of research reports at Thomson Medical Analyst Reports.

Relevant links:
Thomson Medical Share Price History,
Thomson Medical Announcements,
Thomson Medical Dividend Payout Dates & Corporate Actions,
Thomson Medical News






Advertisement

You May Also Like



SGX Stock / REIT Search

Advertisement

Most Read

Trust Bank Referral Code

Advertisement